{
    "accession": "MITE0000042",
    "status": "active",
    "comment": "The enzyme accepts the vancomycin and teicoplanin pseudoaglycone as substrate. The substrate tolerance may be even broader than the largest common substructure between vancomycin and teicoplanin.",
    "changelog": [
        {
            "version": "1",
            "date": "2024-07-30",
            "contributors": [
                "0009-0008-7609-4484"
            ],
            "reviewers": [
                "0000-0001-6534-6609"
            ],
            "comment": "Initial entry. Reviewer 1 reworked reaction SMARTS to allow for a balanced reaction."
        }
    ],
    "enzyme": {
        "name": "GtfD",
        "description": "Transfers vancosamine onto glucose on hpg4 of vancomycin pseudoaglycone.",
        "references": [
            "doi:10.1186/1471-2164-15-363",
            "doi:10.1021/bi036130c",
            "doi:10.1016/S1074-5521(02)00270-3",
            "doi:10.1021/bi010050w"
        ],
        "databaseIds": {
            "uniprot": "P96564",
            "genpept": "AEI58872.1",
            "mibig": "BGC0000455"
        }
    },
    "reactions": [
        {
            "tailoring": [
                "Glycosylation"
            ],
            "reactionSMARTS": "[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24])-[#6@@:21](/[#8:22])-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18])-[#8:16]-1)=[#8:3].[#6:91]/[#6@:92]1-[#6@:124](\\[#8:125])-[#6@:121](-[#7:123])(\\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1>>[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\\[#6:122])-[#6@@:21](/[#8:22])-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18])-[#8:16]-1)=[#8:3].[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97]",
            "reactions": [
                {
                    "substrate": "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O",
                    "products": [
                        "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O",
                        "Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Reaction of UDP-L-4-epi-vancosamine with 6-deoxy-glycosyl-vancomycin-pseudoaglycone."
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1016/S1074-5521(02)00270-3"
                ]
            }
        },
        {
            "tailoring": [
                "Glycosylation"
            ],
            "reactionSMARTS": "[#6:91]/[#6@:92]1-[#6@:124](\\[#8:125])-[#6@:121](-[#7:123])(\\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24])-[#6@@:21](/[#8:22])-[#6:19]-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\\[#6:122])-[#6@@:21](/[#8:22])-[#6:19]-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]",
            "reactions": [
                {
                    "substrate": "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)C[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O",
                    "products": [
                        "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)C[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O",
                        "Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Reaction of UDP-L-4-epi-vancosamine with 4-deoxy-glycosyl-vancomycin-pseudoaglycone."
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1016/S1074-5521(02)00270-3"
                ]
            }
        },
        {
            "tailoring": [
                "Glycosylation"
            ],
            "reactionSMARTS": "[#6:91]/[#6@:92]1-[#6@:124](\\[#8:125])-[#6@:121](-[#7:123])(\\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24])-[#6:21]-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\\[#6:122])-[#6:21]-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]",
            "reactions": [
                {
                    "substrate": "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)C[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O",
                    "products": [
                        "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)C[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O",
                        "Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Reaction of UDP-L-4-epi-vancosamine with 3-deoxy-glycosyl-vancomycin-pseudoaglycone."
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1016/S1074-5521(02)00270-3"
                ]
            }
        },
        {
            "tailoring": [
                "Glycosylation"
            ],
            "reactionSMARTS": "[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24])-[#6@@:21](/[#8:22])-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3].[#6:91]/[#6@:92]1-[#6@:124](\\[#8:125])-[#6@:121](-[#7:123])(\\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1>>[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\\[#6:122])-[#6@@:21](/[#8:22])-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3].[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97]",
            "reactions": [
                {
                    "substrate": "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O",
                    "products": [
                        "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O",
                        "Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Reaction of UDP-L-4-epi-vancosamine with glycosyl-vancomycin-pseudoaglycone."
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1021/bi010050w",
                    "doi:10.1016/S1074-5521(02)00270-3"
                ]
            }
        },
        {
            "tailoring": [
                "Glycosylation"
            ],
            "reactionSMARTS": "[#6:91]/[#6@:92]1-[#6@:124](\\[#8:125])-[#6@:121](-[#7:123])(\\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24])-[#6@@:21](/[#8:22])-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18]-[#7:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\\[#6:122])-[#6@@:21](/[#8:22])-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18]-[#7:200])-[#8:16]-1)=[#8:3]",
            "reactions": [
                {
                    "substrate": "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O",
                    "products": [
                        "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O",
                        "Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Reaction of UDP-L-4-epi-vancosamine with 6-amino-glycosyl-vancomycin-pseudoaglycone."
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1016/S1074-5521(02)00270-3"
                ]
            }
        },
        {
            "tailoring": [
                "Glycosylation"
            ],
            "reactionSMARTS": "[#6:91]/[#6@:92]1-[#6@:124](\\[#8:125])-[#6@:121](-[#7:123])(\\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24])-[#6@@:21](/[#8:22])-[#6@:19](\\[#7:201])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\\[#6:122])-[#6@@:21](/[#8:22])-[#6@:19](\\[#7:201])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]",
            "reactions": [
                {
                    "substrate": "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O",
                    "products": [
                        "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O",
                        "Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Reaction of UDP-L-4-epi-vancosamine with 4-amino-glycosyl-vancomycin-pseudoaglycone."
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1016/S1074-5521(02)00270-3"
                ]
            }
        },
        {
            "tailoring": [
                "Glycosylation"
            ],
            "reactionSMARTS": "[#6:91]/[#6@:92]1-[#6@:124](\\[#8:125])-[#6@:121](-[#7:123])(\\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24])-[#6@@:21](/[#7:201])-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\\[#6:122])-[#6@@:21](/[#7:201])-[#6@:19](\\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]",
            "reactions": [
                {
                    "substrate": "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O",
                    "products": [
                        "CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O",
                        "Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Reaction of UDP-L-4-epi-vancosamine with 3-amino-glycosyl-vancomycin-pseudoaglycone."
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1016/S1074-5521(02)00270-3"
                ]
            }
        }
    ]
}